Immix Biopharma, Inc.IMMXNASDAQ
Loading
Income Quality Over TimeExpanding
Percentile Rank83
3Y CAGR-3.3%
5Y CAGR+18.2%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
-3.3%/yr
Annual compound
5Y CAGR
+18.2%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
20250.81+20.4%
20240.68-7.4%
20230.73-19.0%
20220.90+1281.1%
20210.07-81.5%
20200.35-56.6%
20190.81-